RVPH
NASDAQ · Pharmaceuticals
Reviva Pharmaceuticals Holdi
$0.34
-0.04 (-10.53%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+3,538.2% upside
Low Target
$10.29
Average Target
$12.37
High Target
$18.62
Current Price
$0.34
Current
$0.34
$0.34
Target
$12.37
$12.37
$10.29
$12.37 avg
$18.62
Scenario Analysis
Bear Case
$10.29
2,926.5%
Low target
Base Case
$12.37
+3,538.2%
Avg target
Bull Case
$18.62
+5,376.5%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$15.40
-97.8% from high
52-Week Low
$0.26
+29.8% from low
Target vs 52W High
$12.37
-19.7% vs high
Next Earnings Report
Nov 16, 2026
9d
until earnings
EPS Est: $-0.65
Earnings in 9 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals